GARCIA ERNEST C. II Insider Trading Activity

Also formerly known as GARCIA ERNEST C II
Average Profitability
82.61%
Insider Buys Quantity
6
Insider Buys Sum
$114M
Insider Sells Quantity
421
Insider Sells Sum
$5.8B

Insider Activity of GARCIA ERNEST C. II

According to the SEC Form 4 filings, GARCIA ERNEST C. II, being in a position of

  1. 10 percent owner at Carvana Co.,
    оver the last 12 months, has bought 0 shares, and sold 3555707 shares for $1.24B,
    over all time since 2017-05-03, has bought 4885887 shares for $114M, and sold 40964630 shares for $7.03B.

Biography of GARCIA ERNEST C. II

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,235,686,49054100

Comparison of Insiders on Amount of Buys and Sells

2025-11-14SaleSylvamo Corporation
SLVM
VP, Controller,Chief Acct.Off.
1,000
0.0024%
$45.77$45,770+1.51%
2025-11-14SaleUniversal Electronics Inc.
UEIC
EVP Global Sales
559
0.0042%
$2.96$1,657+0.17%
2025-11-13SaleACRES Commercial Realty Corp.
ACR
10 percent owner
733
–
$25.15$18,435-14.71%
2025-11-13PurchaseAudioEye, Inc.
AEYE
director
6,000
0.0487%
$11.90$71,420-0.87%
2025-11-13SaleAmalgamated Financial Corp.
AMAL
EVP, Chief Legal Officer
3,425
0.0114%
$27.76$95,078+0.4%
2025-11-13SaleA-Mark Precious Metals, Inc.
AMRK
Chief Executive Officer
16,000
0.0665%
$26.04$416,592-2.33%
2025-11-13SaleArtivion, Inc.
AORT
SVP, Clinical & MD Affair
4,993
0.0106%
$45.86$228,969-0.71%
2025-11-13SaleArtivion, Inc.
AORT
SVP, General Counsel
5,761
0.0122%
$45.86$264,188-0.71%
2025-11-13SaleArtivion, Inc.
AORT
Chief Commercial Officer
6,563
0.014%
$45.86$300,966-0.71%
2025-11-13SaleArtivion, Inc.
AORT
President & CEO
34,210
0.0727%
$45.86$1.57M-0.71%
2025-11-13SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
20,000
0.0365%
$63.01$1.26M-0.07%
2025-11-13SaleAXT, Inc.
AXTI
CFO
101,297
0.2133%
$10.14$1.03M+2.98%
2025-11-13PurchaseSaul Centers, Inc.
BFS
Senior Vice President & CFO
450
–
$20.60$9,270+45.15%
2025-11-13SaleBioLife Solutions, Inc.
BLFS
President and CEO
31,165
0.0652%
$25.33$789,409-0.75%
2025-11-13SaleChubb Limited
CB
Executive Vice President and*
5,830
0.0015%
$297.08$1.73M-0.28%
2025-11-13PurchaseCPS Technologies Corporation
CPSH
director
1,500
0.0104%
$3.42$5,127-0.52%
2025-11-13SaleCastellum, Inc.
CTM
General Counsel, Secretary
160,000
0.1677%
$1.17$186,400+0.86%
2025-11-13PurchaseDonegal Group Inc.
DGICA
10 percent owner
29,000
0.0796%
$19.53$566,300+1.86%
2025-11-13SaleDonegal Group Inc.
DGICA
SVP & GENERAL COUNSEL
900
0.0025%
$19.74$17,762+0.78%
2025-11-13SaleDonegal Group Inc.
DGICA
director
4,500
0.0125%
$19.73$88,767+0.83%
Total: 828855
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.